semaglutide podcast Stephan Guyenet, PhD: GLP-1, Semaglutide, and the Big Future of Weight Loss Therapies Community Perspective: FDA OKs Injectable

We understand that weight loss is not one-size-fits-all, and we are committed to providing you with a customized plan that fits your lifestyle

Lost wages: Compensation often includes lost income

Whilst it is unlikely that you will experience them, being able to recognise the symptoms of a serious condition means that you can get medical help more quickly

During the early weeks or after a dose increase, many people feel nausea, lose interest in food, and take in less fluid

Vascular Protection Investigations in vascular calcification models showed: Attenuation of vascular smooth muscle calcification via AMPK activation Reduced expression of osteogenic markers in vascular tissue Protection against secondary myocardial remodeling Prevention of age-related vascular dysfunction Aging and Longevity Research Cellular Aging and Senescence Research examining MOTS-c in aging models revealed: Plasma MOTS-c levels decline approximately 21% between ages 18-30 and 70-81 years in humans Treatment delayed age-related functional decline in multiple mouse organ systems Improved stress resilience in aged mesenchymal stem cells Enhanced mitochondrial homeostasis in aged tissues Studies correlating endogenous MOTS-c levels with aging biomarkers suggest its decline contributes to age-related metabolic deterioration